CareFusion Corp. (CFN)

(NYSE:CFN)

SUMMARY

 
 

CAREFUSION CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of CareFusion Corp. (CFN) Over the Proposed Sale of the Company to Becton, Dickinson & Co.

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of CareFusion Corp. (“CareFusion” or the “Company”) (NYSE:CFN) for potential breaches of fiduciary duties in connection with the sale of the Company to Becton, Dickinson & Co. (“Becton Dickinson”) (NYSE: BDX) in a cash and stock deal valued at approximately $12.2 billion.  The Company’s stockholders will receive $49 in cash and .0777 shares of Becton Dickinson for a total consideration of $58 per share of CareFusion common stock they own. The deal price is subject to change based on Becton Dickinson’s stock price.

Click here for more information: www.faruqilaw.com/CFN. There is no cost or obligation to you.

The investigation focuses on whether CareFusion’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of CareFusion’s shareholders.

If you own common stock in CareFusion and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

 
 

Request Information

 
  Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.
Company:CareFusion Corp. (CFN)
 
 
*Security code:
 
   
 
 

Contact Counsel

Juan E. Monteverde
Faruqi & Faruqi, LLP
369 Lexington Avenue 10th Floor
New York, NY 10017
Tel: (212) 983-9330
Email:  jmonteverde@faruqilaw.com

Send Information

If you have information regarding this case that you would
like to make available, please click here to contact us
about our investigation

Case Details